BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi SW, Tu ZG, Peng WJ, Wang LX, Ou-Yang X, Cai AJ, Dai Y. 1H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis. World J Gastroenterol 2012; 18(3): 285-290 [PMID: 22294833 DOI: 10.3748/wjg.v18.i3.285] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Lisuzzo A, Laghi L, Faillace V, Zhu C, Contiero B, Morgante M, Mazzotta E, Gianesella M, Fiore E. Differences in the serum metabolome profile of dairy cows according to the BHB concentration revealed by proton nuclear magnetic resonance spectroscopy (1H-NMR). Sci Rep 2022;12:2525. [PMID: 35169190 DOI: 10.1038/s41598-022-06507-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hershberger CE, Rodarte AI, Siddiqi S, Moro A, Acevedo-Moreno LA, Brown JM, Allende DS, Aucejo F, Rotroff DM. Salivary Metabolites are Promising Non-Invasive Biomarkers of Hepatocellular Carcinoma and Chronic Liver Disease. Liver Cancer Int 2021;2:33-44. [PMID: 34541549 DOI: 10.1002/lci2.25] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Raja G, Gupta H, Gebru YA, Youn GS, Choi YR, Kim HS, Yoon SJ, Kim DJ, Kim TJ, Suk KT. Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications. Int J Mol Sci 2021;22:1160. [PMID: 33503844 DOI: 10.3390/ijms22031160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
4 Beyoğlu D, Idle JR. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020;10:E50. [PMID: 32012846 DOI: 10.3390/metabo10020050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 8.5] [Reference Citation Analysis]
5 Yoo HJ, Jung KJ, Kim M, Kim M, Kang M, Jee SH, Choi Y, Lee JH. Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls. Front Physiol 2019;10:1421. [PMID: 31803070 DOI: 10.3389/fphys.2019.01421] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
6 Vignoli A, Orlandini B, Tenori L, Biagini MR, Milani S, Renzi D, Luchinat C, Calabrò AS. Metabolic Signature of Primary Biliary Cholangitis and Its Comparison with Celiac Disease. J Proteome Res 2019;18:1228-36. [PMID: 30539636 DOI: 10.1021/acs.jproteome.8b00849] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
7 Khan V, Putluri N, Sreekumar A, Mindikoglu AL. Current Applications of Metabolomics in Cirrhosis. Metabolites 2018;8:E67. [PMID: 30360420 DOI: 10.3390/metabo8040067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Chen Y, Zhou J, Li J, Feng J, Chen Z, Wang X. Plasma metabolomic analysis of human hepatocellular carcinoma: Diagnostic and therapeutic study. Oncotarget 2016;7:47332-42. [PMID: 27322079 DOI: 10.18632/oncotarget.10119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
9 Batista AD, Barros CJP, Costa TBBC, Godoy MMG, Silva RD, Santos JC, de Melo Lira MM, Jucá NT, Lopes EPA, Silva RO. Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis. World J Hepatol 2018; 10(1): 105-115 [PMID: 29399284 DOI: 10.4254/wjh.v10.i1.105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Le Corvec M, Jezequel C, Monbet V, Fatih N, Charpentier F, Tariel H, Boussard-Plédel C, Bureau B, Loréal O, Sire O, Bardou-Jacquet E. Mid-infrared spectroscopy of serum, a promising non-invasive method to assess prognosis in patients with ascites and cirrhosis. PLoS One 2017;12:e0185997. [PMID: 29020046 DOI: 10.1371/journal.pone.0185997] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
11 Qi S, Huang S, Chen X, Huo Q, Xie N, Xia J. Liver tissue metabolic profiling and pathways of non-alcoholic steatohepatitis in rats: Analysis of non-alcoholic steatohepatitis. Hepatol Res 2017;47:1484-93. [DOI: 10.1111/hepr.12876] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Le Moyec L, Triba M, Nahon P, Bouchemal N, Hantz E, Goossens C. Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolism (Review). Biomed Reports. 2017;6:387-395. [PMID: 28413636 DOI: 10.3892/br.2017.868] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
13 Hou Q, Duan ZJ. Metabonomic window into hepatitis B virus-related hepatic diseases. World J Hepatol 2016; 8(1): 1-8 [PMID: 26783418 DOI: 10.4254/wjh.v8.i1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Amathieu R, Triba MN, Goossens C, Bouchemal N, Nahon P, Savarin P, Le Moyec L. Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications. World J Gastroenterol 2016; 22(1): 417-426 [PMID: 26755887 DOI: 10.3748/wjg.v22.i1.417] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
15 Fages A, Duarte-Salles T, Stepien M, Ferrari P, Fedirko V, Pontoizeau C, Trichopoulou A, Aleksandrova K, Tjønneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Severi G, Kaaks R, Kuhn T, Floegel A, Boeing H, Lagiou P, Bamia C, Trichopoulos D, Palli D, Pala V, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Agudo A, Molina-Montes E, Huerta JM, Ardanaz E, Dorronsoro M, Sjöberg K, Ohlsson B, Khaw KT, Wareham N, Travis RC, Schmidt JA, Cross A, Gunter M, Riboli E, Scalbert A, Romieu I, Elena-Herrmann B, Jenab M. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med 2015;13:242. [PMID: 26399231 DOI: 10.1186/s12916-015-0462-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
16 Sands CJ, Guha IN, Kyriakides M, Wright M, Beckonert O, Holmes E, Rosenberg WM, Coen M. Metabolic Phenotyping for Enhanced Mechanistic Stratification of Chronic Hepatitis C-Induced Liver Fibrosis. American Journal of Gastroenterology 2015;110:159-69. [DOI: 10.1038/ajg.2014.370] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
17 Lam C, Law C, To KK, Cheung SK, Lee K, Sze K, Leung K, Yuen K. NMR-based metabolomic urinalysis: A rapid screening test for urinary tract infection. Clinica Chimica Acta 2014;436:217-23. [DOI: 10.1016/j.cca.2014.05.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
18 Duarte IF, Diaz SO, Gil AM. NMR metabolomics of human blood and urine in disease research. Journal of Pharmaceutical and Biomedical Analysis 2014;93:17-26. [DOI: 10.1016/j.jpba.2013.09.025] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 9.1] [Reference Citation Analysis]
19 Sun L, Zhang H, Wu L, Shu S, Xia C, Xu C, Zheng J. 1H-Nuclear magnetic resonance-based plasma metabolic profiling of dairy cows with clinical and subclinical ketosis. Journal of Dairy Science 2014;97:1552-62. [DOI: 10.3168/jds.2013-6757] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
20 Nishikawa T, Bellance N, Damm A, Bing H, Zhu Z, Handa K, Yovchev MI, Sehgal V, Moss TJ, Oertel M. A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol. 2014;60:1203-1211. [PMID: 24583248 DOI: 10.1016/j.jhep.2014.02.014] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 8.0] [Reference Citation Analysis]
21 Amathieu R, Triba MN, Nahon P, Bouchemal N, Kamoun W, Haouache H, Trinchet JC, Savarin P, Le Moyec L, Dhonneur G. Serum 1H-NMR metabolomic fingerprints of acute-on-chronic liver failure in intensive care unit patients with alcoholic cirrhosis. PLoS One 2014;9:e89230. [PMID: 24586615 DOI: 10.1371/journal.pone.0089230] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
22 Beyoğlu D, Idle JR. The metabolomic window into hepatobiliary disease. J Hepatol 2013;59:842-58. [PMID: 23714158 DOI: 10.1016/j.jhep.2013.05.030] [Cited by in Crossref: 125] [Cited by in F6Publishing: 137] [Article Influence: 13.9] [Reference Citation Analysis]
23 Seijo S, Lozano JJ, Alonso C, Reverter E, Miquel R, Abraldes JG, Martinez-Chantar ML, Garcia-Criado A, Berzigotti A, Castro A, Mato JM, Bosch J, Garcia-Pagan JC. Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension. Am J Gastroenterol. 2013;108:926-932. [PMID: 23419380 DOI: 10.1038/ajg.2013.11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]